ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SBTX Skinbiotherapeutics Plc

10.15
0.40 (4.10%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 4.10% 10.15 10.00 10.30 10.15 9.75 9.75 686,106 13:43:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -6.23 17.66M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 9.75p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £17.66 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -6.23.

Skinbiotherapeutics Share Discussion Threads

Showing 7051 to 7073 of 23750 messages
Chat Pages: Latest  290  289  288  287  286  285  284  283  282  281  280  279  Older
DateSubjectAuthorDiscuss
25/7/2020
13:10
And when that happens you won't be able to buy at anything less than 50p. It still stuns me that people do not see that.
madaboutmed
25/7/2020
12:41
Perhaps it will take one more deal within a different segment (Medibiotix or Cleanbiotix) and the wider investment community will cotton on.
parob
25/7/2020
12:22
Lol.

It is hard to keep a sensible view here.

Psoriasis - launch will be well ahead of schedule and revenue earning. SA wants to use the psoriasis community to self market as the product is very much needed.

Croda/sederma - Elric one for you here. I was both surprised but very excited by mention of matrixyl in the cenkos note and especially with regards it’s longevity as a revenue earner. It’s one thing is speculating it’s another when a respected research house specifically mentions it and goes into detail.

Woundcare and cleanbiotix - obviously lots going on here and I wouldn’t rule out a major announcement at any time tbh. Discussions have been going on a long time and have expanded in scope according BF to SA.

I found his comment in Elric’s interview very positive when he said I will let you work that one out after he mentioned about big pharma that make revenues from non elective surgery were looking for other areas to fund research.

For a small company there is a lot going on here and we are definitely in the right sector.

S

shrewdmole
25/7/2020
09:48
Now closed at a years high according to my chart. So an early indicator that a catalyst could be playing out.

Hopefully the start of a nice up-trend over the medium to long term.

pj 1
25/7/2020
08:26
SkinBioTherapeutics says development project with Winclove is well ahead of scheduleThe skin health specialist made significant progress with its collaborative partners, Winclove Probiotics and CrodahTTps://tinyurl.com/y9x5wxrn"We are very pleased with the progress that the company has been able to make during these most exceptional times. Our development projects are making great progress, as evidenced by our AxisBiotix formulation with Winclove being completed significantly ahead of schedule," Stuart Ashman, the chief executive officer of SkinBio said in the update."Work with Croda's Sederma team is progressing well and to plan and we are extending our IP [intellectual property] portfolio, with the new patent being granted in multiple geographies."The next milestones for us are establishing a new rapid trial protocol for AxisBiotix Ps that is resistant to the pressures of the ongoing COVID-19 restrictions and continuing to advance our MediBiotix and CleanBiotix programmes," he added.
parob
24/7/2020
15:53
Now you can buy up to 180000 shares at 20.25p so
maybe a sell order is being processed?
At least the price is up a little.

1crunchy
24/7/2020
15:45
Clarification acknowledged, thanks.
rafboy
24/7/2020
15:38
Raf
correction I meant 7500 shares(what does one 0 matter)
However as you probably know to buy is 20.25
and sell just under around 19.9
ATB :)

1crunchy
24/7/2020
15:32
Thanks crunchy.
rafboy
24/7/2020
15:25
Raf
You are only allowed to buy in tranches of 750 shares at 20p
yet you can sell up to 30000 shares at 20p above that it goes down
to about 19.7

1crunchy
24/7/2020
15:18
Observation.

I don't need any more. You suit yourself.

eeza
24/7/2020
15:16
eeza24 Jul '20 - 15:02 - 6069 of 6070
0 1 0
Only when the MM's have offloaded the shares they've been given to sell.

Someone is abusing the system by not declaring 1% moves in the share price
=============================================================================

What evidence do you have of that?

pj 1
24/7/2020
15:10
Interesting.
rafboy
24/7/2020
15:02
Only when the MM's have offloaded the shares they've been given to sell.

Someone is abusing the system by not declaring 1% moves in the share price

eeza
24/7/2020
14:58
Parob, you would think so.
rafboy
24/7/2020
14:55
They must be kills or fills raf!Surely they will have to move it up soon.
parob
24/7/2020
14:54
There are still buys going through or are they sells at 20p!
rafboy
24/7/2020
14:50
Can sell 100K above mid price.But cannot even buy 200 without going to NT!
parob
24/7/2020
14:05
Parob

What are online limits like?

S

shrewdmole
24/7/2020
13:49
Nice to see the interest today. Perhaps we can get back to where we were, nearer 30p.
rafboy
24/7/2020
13:47
NT for just 500 shares!
parob
24/7/2020
13:45
1 sell at 19.86 soon dropped the bid back to 19.50p. Not done yet.
eeza
24/7/2020
13:38
19.80p bid to 20.00p offer.

Is the seller running out of stock, or taking the boot off the throat to allow strength back into the share price

eeza
Chat Pages: Latest  290  289  288  287  286  285  284  283  282  281  280  279  Older